![](https://www.swissinfo.ch/content/wp-content/uploads/sites/13/2024/07/232c7eeaa1e43255266dd101e1e5a4c6-84068772.jpg?fit=1200,900)
Swiss giant Roche given green light for lung cancer drug in Canada
Roche: Canadian green light for Alecensaro drug Keystone-SDA Roche has been granted marketing authorisation for its drug Alecensaro by Health Canada. Alecensaro is an adjunct therapy for patients with early-stage ALK-positive lung cancer. This content was …